Hemodynamics and Mid-Term Clinical Outcomes Following Valve-in-Valve TAVR With Balloon-Expandable Valves.
Document Type
Article
Publication Date
2-9-2026
Publication Title
Circulation. Cardiovascular interventions
Abstract
BACKGROUND: Lower (< 10 mm Hg) discharge echocardiographic mean gradients (MGs) following transcatheter aortic valve replacement with balloon-expandable valves are associated with lower ejection fraction and higher 5-year mortality compared with higher gradients. Using the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry, we studied the relationship between echocardiographic MG and patient prosthesis mismatch (PPM) following transcatheter aortic valve-in-valve replacement and clinical outcomes.
METHODS: Patients who underwent aortic valve-in-valve replacement with a balloon-expandable valve from July 2015 to December 2023 in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry were included. Adjusted Cox models with regression splines explored the relationship between MG and 5-year mortality. Kaplan-Meier estimates and adjusted hazard ratios compared the occurrence of 5-year mortality between gradient cutoffs and PPM presence.
RESULTS: A total of 13 054 patients were included; spline curves demonstrated a nonlinear relationship between discharge MG and 5-year mortality. Kaplan-Meier curves suggested higher 5-year mortality with MG < 10 mm Hg compared with MG ≥10 mm Hg (hazard ratio, 1.15 [95% CI, 1.02-1.29];
CONCLUSIONS: Discharge MG < 10 mm Hg are associated with lower ejection fraction and increased 5-year mortality following aortic valve-in-valve replacement compared with higher MG in a nonlinear fashion. Incorporating data on ejection fraction with PPM and MG is important before determining the need for valve optimization.
First Page
e015945
Recommended Citation
Abbas AE, Kaneko T, Khalili H, Kapadia SR, Babaliaros VC, Greenbaum AB et al [Schwann TA]. Hemodynamics and mid-term clinical outcomes following valve-in-valve tavr with balloon-expandable valves. Circ Cardiovasc Interv. 2026 Feb 9:e015945. doi: 10.1161/CIRCINTERVENTIONS.125.015945. Epub ahead of print. PMID: 41657207.
DOI
10.1161/CIRCINTERVENTIONS.125.015945
ISSN
1941-7632
PubMed ID
41657207